Plaxovid, the antiviral pill in opposition to COVID-19 by Pfizer that has been accepted by EMA, is anticipated in Cyprus by mid-February, Deputy Director of the Ministry of Well being`s Pharmaceutical Providers Dr. Elena Panagiotopoulou has informed CNA, including that it is going to be in a position for use within the remedy of over 15,000 sufferers.
In statements to CNA on Friday, Panagiotopoulou mentioned this would be the second antiviral capsule for use in Cyprus, which is as much as 90% efficient within the prevention of hospitalisation and demise of high-risk sufferers as a consequence of COVID-19, in response to Pfizer. Primarily based on the most recent laboratory knowledge, the medication can also be efficient in opposition to the Omicron variant, she added.
Plaxovid is the primary of the 2 medicines accepted by the Committee for Medicinal Merchandise for Human Use (CHMP) of the European Medical Affiliation (EMA), mentioned Panagiotopoulou and it was licensed by an emergency course of for early use, because of the quick unfold of the Omicron variant.
Panagiotopoulou defined that the opposite medication, Molnupiravir 200mg onerous capsules, which is already accessible in Cyprus, has been accepted by the EMA, however just isn’t licensed but.
She additionally talked about that Plaxovid just isn’t appropriate for pregnant ladies or moms who breastfeed, nor for folks with kidney failure. Private docs and docs of different specialities will prescribe the capsule, in response to protocols ready by the Advert Hoc Committee, and sufferers will be capable of decide it up solely from hospital pharmacies.
The Well being Ministry official mentioned that 125 sufferers have been handled with Molnupravir up to now in Cyprus, with none undesirable unintended effects.
The protein-based vaccine by Novavax anticipated by the top of February
Concerning the arrival of the protein-based vaccine by Novavax, she mentioned that it’s anticipated by the top of February, each in Cyprus and the remainder of Europe.
The vaccine comprises a non-infectious part on the floor of the Sars-CoV-2 virus, which induces a protecting immune response when the physique’s immune cells come into contact with it.